Justin Lappen, MD
Additional Locations
Treatment & Services
- Maternal and Fetal Medicine
- Reproductive Health
- Section of Maternal-Fetal Medicine
- Surgical Obstetrics
Specialty in Diseases & Conditions
- Cardiovascular Disease in Pregnancy
- Connective Tissue Diseases
- Hypertension in Pregnancy
- Medical Disorders in Pregnancy
- Placenta Accreta Spectrum Disorders
- Preconception/Interconception Care
Insurance
Is Cleveland Clinic Part of Your Insurance?
Review a list of accepted insurance plans for our Northeast Ohio locations or learn more about purchasing a contracted managed care plan.
View All PlansAbout Justin Lappen, MD
Justin R. Lappen, MD is the Section Head of Maternal Fetal Medicine at Cleveland Clinic and is an Associate Professor of Reproductive Biology at the Cleveland Clinic Lerner College of Medicine, Case Western Reserve University. Dr. Lappen received a Bachelor of Arts degree in Mathematics from Columbia University and his Medical Degree from Johns Hopkins University School of Medicine. He completed residency training in Obstetrics and Gynecology at Prentice Women's Hospital, Northwestern University School of Medicine and fellowship in Maternal Fetal Medicine at MetroHealth Medical Center, Case Western Reserve University School of Medicine.
Dr. Lappen has a passion for interdisciplinary clinical work and research at the intersection of Obstetrics and Critical Care medicine, including maternal cardiac disease, sepsis, and placenta accreta spectrum disorders. He has completed numerous observational studies and prospective trials on obstetric early warning systems and the evaluation of maternal volume status, as well as research in other areas of Obstetrics and Maternal Fetal Medicine. He is the funded principal investigator for a state-wide quality initiative focused on reducing maternal morbidity/mortality and health disparities related to hypertensive disorders of pregnancy. He has published extensively in peer-reviewed journals, received institutional research grants, and serves as a reviewer for multiple journals in Obstetrics and Maternal Fetal Medicine. Dr. Lappen has served on national committees including the National Partnership for Maternal Safety Committee on Vital Sign Triggers and holds national leadership roles as a member of the Reproductive Health Services Advisory Group and Publications Committee through the Society for Maternal Fetal Medicine.
Education & Professional Highlights
Appointed
2020
Education & Fellowships
Fellowship - MetroHealth Medical Center
Maternal Fetal Medicine Fellowship
Cleveland,
OH USA
2017
Residency - McGaw Medical Center of Northwestern University
Obstetrics and Gynecology Residency
Chicago,
IL USA
2010
Medical Education - Johns Hopkins School of Medicine
Medicine
Baltimore,
MD USA
2006
Undergraduate - Columbia University
Mathematics
New York,
NY USA
2002
Certifications
- Obstetrics and Gynecology - Maternal-Fetal Medicine
- Obstetrics and Gynecology
Research & Publications
See publications for Justin Lappen, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 6/22/2023, Dr. Lappen has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
